Findings were similar for MASLD-CSF; postmenopausal women had lower odds of MASLD-CSF compared to men (0.43 [0.20–0.96], P = .04) but the comparison between pre-/perimenopausal women and men did not reach statistical significance (0.40 [0.15–1.05], P = .06) ( Supplementary Table 2 ).
← all excerpts
Female Sex is Protective Against MASLD With Clinically Significant Fibrosis in a Large Cross-sectional Cohort of Persons With HIV.
2
0.0600
0.0700
The sentences
Though the effect size was similar for pre-/perimenopausal women versus men, this comparison failed to reach statistical significance (0.65 [0.41–1.03], P = .07) ( Supplementary Table 1 ).